C-Reactive Protein Testing Market Analysis 2024 -2033: Forecasted Market Size, Top Segments, And Largest Region | Thermo Fisher Scientific Inc., F Hoffmann-La Roche AG, Danaher Corporation, Quest Diagnostics Incorporated

The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2250

The Business Research Company offers in-depth market insights through C-Reactive Protein Testing Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.

Market Size And Growth Forecast:
The c-reactive protein testing market size has grown steadily in recent years. It will grow from $3.43 billion in 2023 to $3.55 billion in 2024 at a compound annual growth rate (CAGR) of 3.6%. The growth in the historic period can be attributed to increased inflammatory disease prevalence, cardiovascular risk assessment, increased aging population, increased healthcare infrastructure, and healthcare screening programs.

The c-reactive protein testing market size is expected to see steady growth in the next few years. It will grow to $4.16 billion in 2028 at a compound annual growth rate (CAGR) of 4.1%. The growth in the forecast period can be attributed to rising obesity rates, personalized medicine and biomarkers, telehealth and remote monitoring, early disease detection, and lifestyle-related inflammation
. Major trends in the forecast period include diagnostic testing advancements, wearable health technology, technological solutions, strategic collaborations, and industry 4.0 introduction.

Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=6719&type=smp

Market Segmentation:
The main types of assays in c-reactive protein testing market are enzyme-linked immunosorbent assay (ELISA), chemiluminescence immunoassay (CLIA) and immunoturbidimetric assays. The enzyme-linked immunosorbent assay (ELISA) is used to measure CRP (c-reactive protein). C-reactive protein (CRP) ELISA test offers quantitative measurement of human c-reactive protein in serum to help in the follow-up of rheumatic fever, inflammatory processes, and others. Elisa is a biological assay that measures antibodies, antigens, proteins, and glycoproteins. The c-reactive protein testing is mainly used in clinics, hospitals and diagnostic laboratories for diseases such as diabetes, rheumatoid arthritis, cardiovascular disease, inflammatory bowel disease, cancer and others.

Major Driver - Cardiovascular Disease Epidemic And The Vital Role Of C-Reactive Protein Testing In Market Growth
The increase in cases of cardiovascular diseases (CVD) are expected to propel the growth of the c-reactive protein testing market. Cardiovascular diseases refer to heart conditions such as diseased vessels, structural problems, and blood clots. The exact cause of CVD is uncertain, but numerous factors can increase the risk of developing it. One such factor is the behavioral risk caused due to unbalanced eating, lack of physical activity, smoking, and alcohol use, which results in an accumulation of fatty deposits inside the arteries (atherosclerosis), resulting in an increased risk of blood clots. These behavioral risks result in elevated blood pressure, glucose, blood lipids, weight gain, and obesity. The increasing cases of cardiovascular diseases invites the need for c-reactive protein testing to diagnose or predict the chance of having cardiovascular problems at least as well as cholesterol levels. For instance, according to the key facts published in June 2021 by the WHO (World Health Organization), cardiovascular diseases are the leading cause of death worldwide. Around 17.9 million die every year due to CVD, accounting for 32% of all global deaths. Therefore, the increasing cases of cardiovascular diseases will drive the c-reactive protein testing market growth.

Competitive Landscape:
Major companies operating in the c-reactive protein testing market include Thermo Fisher Scientific Inc., F Hoffmann-La Roche AG, Danaher Corporation, Quest Diagnostics Incorporated, Siemens AG, Abbott Laboratories, Abaxis Inc., Aidian Oy, Boditech Med Inc., Horiba Ltd., Laboratory Corporation, Merck KGAA, Randox Laboratories Limited, Getein Biotech Inc., ProciseDx LLC, Bio-Rad Laboratories Inc., DiaSorin S.p.A., Eurofins Scientific SE, Inova Diagnostics Inc., Luminex Corporation, Johnson & Johnson Clinical Diagnostics, Sekisui Diagnostics LLC, Sysmex Corporation, Tosoh Corporation, Trinity Biotech Plc, WerfenLife Group LLC, ZEUS Scientific Inc., BioMérieux SA, Biomerica Inc., Corgenix Medical Corporation, Gold Standard Diagnostics Corp., Immunodiagnostic Systems Holdings PLC, Nova Biomedical Corporation

Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/c-reactive-protein-testing-global-market-report

Top Trend - Technological Advancements Transforming The C-Reactive Protein Testing Market
Technological advancement in measuring devices is a key trend in the c-reactive protein testing market. Major companies operating in the c-reactive protein testing market are focused on providing technologically advanced solutions to strengthen their market position. These companies are implementing next-generation c-reactive testing technologies into their testing methods and advanced solutions that provide benefits such as maximum output and multiple usages. For instance, in February 2022, Aidian, a Finnish-based diagnostic tests, and test solutions company, released the QuikRead go wrCRP & wrCRP+Hb kits. The kit consistently produces two results, a wide range of CRP and Hb, from a single sample with one analysis. The wide-range CRP test permits CRP readings to assess conditions such as neonatal sepsis, predict disease severity in COPD (chronic obstructive pulmonary disease), and assist in cardiovascular risk assessment.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. C-Reactive Protein Testing Market Characteristics
3. C-Reactive Protein Testing Market Trends And Strategies
4. C-Reactive Protein Testing Market - Macro Economic Scenario
5. C-Reactive Protein Testing Market Size And Growth
…..
27. C-Reactive Protein Testing Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

This release was published on openPR.